Core Scientific, Inc. CORZ NASDAQ

Core Scientific, Inc. (CORZ) reported total assets of $2.35B and total liabilities of $3.31B for quarter ending 2025-12-31, resulting in total equity of $-962.74M.

The company held $311.38M in cash and short-term investments. Total debt stood at $1.06B, with net debt of $748.95M. The Debt-to-Equity (D/E) ratio was -1.1 (conservative).

Current ratio is 1.15, suggesting adequate short-term liquidity. Interest coverage is 14.2x (strong).

Criteria supported by this page:

• HEALTH (25/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (42/100) — Total assets $2.35B and equity $-962.74M support the company's competitive scale
• VALUE (90/100) — Debt-to-Equity -1.1 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 39/100 with 2/7 criteria passed.